(Q38600327)

4 September 2017

Drug-Induced Diabetes Mellitus: Evidence for Statins and Other Drugs Affecting Glucose Metabolism (English)

1 reference

4 September 2017

R Donnelly

3

0 references

author name string

U Anyanwagu

series ordinal

1

1 reference

PubMed ID

26440603

4 September 2017

I Idris

series ordinal

2

1 reference

PubMed ID

26440603

4 September 2017

language of work or name

English

0 references

publication date

6 October 2015

1 reference

Clinical Pharmacology & Therapeutics

4 September 2017

1 reference

4 September 2017

99

1 reference

4 September 2017

4

1 reference

4 September 2017

390-400

1 reference

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

4 September 2017

1 reference

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative.

21 January 2018

1 reference

Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials

21 January 2018

1 reference

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

21 January 2018

1 reference

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Rosuvastatin in older patients with systolic heart failure

21 January 2018

1 reference

Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus

21 January 2018

1 reference

Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials

21 January 2018

1 reference

Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases.

21 January 2018

1 reference

Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis

21 January 2018

1 reference

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial

21 January 2018

1 reference

Risk of incident diabetes among patients treated with statins: population based study.

21 January 2018

1 reference

Statins, risk of diabetes, and implications on outcomes in the general population.

21 January 2018

1 reference

Statins and risk of treated incident diabetes in a primary care population

21 January 2018

1 reference

Primary prevention with statins and incident diabetes in hypertensive patients at high cardiovascular risk

21 January 2018

1 reference

Diabetes mellitus and cardiovascular events in older patients with myocardial infarction prescribed intensive-dose and moderate-dose statins.

21 January 2018

1 reference

Statins and risk of diabetes: an analysis of electronic medical records to evaluate possible bias due to differential survival

21 January 2018

1 reference

Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort.

21 January 2018

1 reference

Differential impact of statin on new-onset diabetes in different age groups: a population-based case-control study in women from an asian country

21 January 2018

1 reference

Risk of new-onset diabetes mellitus versus reduction in cardiovascular events with statin therapy

21 January 2018

1 reference

Statins use is associated with poorer glycaemic control in a cohort of hypertensive patients with diabetes and without diabetes.

21 January 2018

1 reference

Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes---the CORALL study

21 January 2018

1 reference

Statin treatment and new-onset diabetes: a review of proposed mechanisms.

21 January 2018

1 reference

Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control

21 January 2018

1 reference

Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis

21 January 2018

1 reference

Fluvastatin causes NLRP3 inflammasome-mediated adipose insulin resistance.

21 January 2018

1 reference

Effects of atorvastatin and pravastatin on signal transduction related to glucose uptake in 3T3L1 adipocytes

21 January 2018

1 reference

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients

21 January 2018

1 reference

New onset diabetes during antihypertensive therapy

21 January 2018

1 reference

Cardiovascular drugs that increase the risk of new-onset diabetes

21 January 2018

1 reference

Thiazide diuretics in the treatment of hypertension: an update

21 January 2018

1 reference

Thiazide effects and adverse effects: insights from molecular genetics

21 January 2018

1 reference

Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications

21 January 2018

1 reference

Adverse prognostic significance of new diabetes in treated hypertensive subjects

21 January 2018

1 reference

Antihypertensive drugs and new-onset diabetes: a retrospective longitudinal cohort study

21 January 2018

1 reference

A retrospective longitudinal cohort study of antihypertensive drug use and new-onset diabetes in Taiwanese patients

21 January 2018

1 reference

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

21 January 2018

1 reference

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 January 2018

1 reference

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

21 January 2018

1 reference

Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics

21 January 2018

1 reference

Thiazide diuretics, potassium, and the development of diabetes: a quantitative review

21 January 2018

1 reference

Opposing effects of β blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery disease

21 January 2018

1 reference

Metabolic sequelae of β-blocker therapy: weighing in on the obesity epidemic?

21 January 2018

1 reference

Effect of ramipril on the incidence of diabetes

21 January 2018

1 reference

The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes

21 January 2018

1 reference

Effects of niacin on the incidence of new onset diabetes and cardiovascular events in patients with normoglycaemia and impaired fasting glucose.

21 January 2018

1 reference

Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed.

21 January 2018

1 reference

Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

21 January 2018

1 reference

Wired on sugar: the role of the CNS in the regulation of glucose homeostasis

21 January 2018

1 reference

Almost all antipsychotics result in weight gain: a meta-analysis

21 January 2018

1 reference

Do antipsychotics increase diabetes risk in children and adolescents?

21 January 2018

1 reference

Antipsychotics-induced metabolic alterations: focus on adipose tissue and molecular mechanisms

21 January 2018

1 reference

Effects of antipsychotic medications on appetite, weight, and insulin resistance

21 January 2018

1 reference

Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients

21 January 2018

1 reference

A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls

21 January 2018

1 reference

Risk for incident diabetes mellitus following initiation of second-generation antipsychotics among Medicaid-enrolled youths.

21 January 2018

1 reference

First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis

21 January 2018

1 reference

Antipsychotics in Adults With Schizophrenia: Comparative Effectiveness of First-Generation Versus Second-Generation Medications

21 January 2018

1 reference

Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder

21 January 2018

1 reference

Diabetes risk potentially underestimated in youth and children receiving antipsychotics.

21 January 2018

1 reference

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment.

21 January 2018

1 reference

Prevalence and pathogenesis of diabetes mellitus in HIV-1 infection treated with combined antiretroviral therapy

21 January 2018

1 reference

Adverse effects of antiretroviral therapy

21 January 2018

1 reference

[Risk of type 2 diabetes mellitus associated with statin therapy: evidence and possible mechanisms]

21 January 2018

1 reference

7 January 2021

A double-blind, placebo-controlled, crossover trial comparing the effects of amiloride and hydrochlorothiazide on glucose tolerance in patients with essential hypertension

1 reference

7 January 2021

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.

1 reference

7 January 2021

The effects of HIV protease inhibitors on carbohydrate and lipid metabolism

1 reference

7 January 2021

Identifiers

DOI

10.1002/CPT.274

1 reference

4 September 2017

1 reference

PubMed ID

26440603